Share：
Share this content in WeChat
X
[Chinese][PDF]2194
• Case Report •
Primery neuroendocrine tumor of the mesentery: A case report
ZHANG Yifei  BAO Haihua  LONG Changyou  TIAN Pengqi 

Cite this article as: ZHANG Y F, BAO H H, LONG C Y, et al. Primery neuroendocrine tumor of the mesentery: A case report[J]. Chin J Magn Reson Imaging, 2024, 15(2): 164-166. DOI:10.12015/issn.1674-8034.2024.02.025.


[Keywords] mesentery；neuroendocrine tumor；magnetic resonance imaging；diffusion weighted imaging；pathology；differential diagnosis

ZHANG Yifei   BAO Haihua*   LONG Changyou   TIAN Pengqi  

Image Center of Affiliated Hospital of Qinghai University, Xining 810001

Corresponding author: BAO H H, E-mail: baohelen2@sina.com

Conflicts of interest   None.

Received  2023-05-13
Accepted  2023-10-27
DOI: 10.12015/issn.1674-8034.2024.02.025
Cite this article as: ZHANG Y F, BAO H H, LONG C Y, et al. Primery neuroendocrine tumor of the mesentery: A case report[J]. Chin J Magn Reson Imaging, 2024, 15(2): 164-166. DOI:10.12015/issn.1674-8034.2024.02.025.

[1]
ÖBERG K E. Gastrointestinal neuroendocrine tumors[J/OL]. Ann Oncol, 2010, 21(Suppl 7): vii72-vii80 [2023-03-21]. https://pubmed.ncbi.nlm.nih.gov/20943646/. DOI: 10.1093/annonc/mdq290.
[2]
PAVEL M, ÖBERG K, FALCONI M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2020, 31(7): 844-860. DOI: 10.1016/j.annonc.2020.03.304.
[3]
DANTI G, FLAMMIA F, MATTEUZZI B, et al. Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging[J]. Radiol Med, 2021, 126(12): 1497-1507. DOI: 10.1007/s11547-021-01408-x.
[4]
COSTANZO A, CANZIANI M, FERRARI C C, et al. An apparent primitive mass of the mesentery: A case report[J/OL]. Medicine, 2022, 101(24): e29464 [2023-03-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276447/. DOI: 10.1097/MD.0000000000029464.
[5]
BEDNARCZUK T, ZEMCZAK A, BOLANOWSKI M, et al. Neuroendocrine neoplasms of the small intestine and the appendix - update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours)[Nowotwory neuroendokrynne jelita cienkiego i wyrostka robaczkowego-uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)[J]. Endokrynol Pol, 2022, 73(3): 549-583. DOI: 10.5603/EP.a2022.0052.
[6]
GONZÁLES-YOVERA J G, ROSEBOOM P J, CONCEPCIÓN-ZAVALETA M, et al. Diagnosis and management of small bowel neuroendocrine tumors: A state-of-the-art[J]. World J Methodol, 2022, 12(5): 381-391. DOI: 10.5662/wjm.v12.i5.381.
[7]
FANG J M, LI J, SHI J Q. An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms[J]. World J Gastroenterol, 2022, 28(10): 1009-1023. DOI: 10.3748/wjg.v28.i10.1009.
[8]
YAO J C, HASSAN M, PHAN A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States[J]. J Clin Oncol, 2008, 26(18): 3063-3072. DOI: 10.1200/JCO.2007.15.4377.
[9]
WANG L X, LIU K, LIN G W, et al. Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology[J/OL]. Cancer Imaging, 2015, 15(1): 13 [2023-04-17]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536757/. DOI: 10.1186/s40644-015-0046-0.
[10]
DOHAN A, FATTACH H E, BARAT M, et al. Neuroendocrine tumors of the small bowel: evaluation with MR-enterography[J]. Clin Imaging, 2016, 40(3): 541-547. DOI: 10.1016/j.clinimag.2015.12.016.
[11]
REZNEK R H. CT/MRI of neuroendocrine tumours[J]. Cancer Imaging, 2006, 6(Spec No A): S163-S177. DOI: 10.1102/1470-7330.2006.9037.
[12]
KHANNA L, PRASAD S R, SUNNAPWAR A, et al. Pancreatic neuroendocrine neoplasms: 2020 update on pathologic and imaging findings and classification[J]. Radiographics, 2020, 40(5): 1240-1262. DOI: 10.1148/rg.2020200025.
[13]
ROBERTIS R D, CINGARLINI S, TINAZZI MARTINI P, et al. Pancreatic neuroendocrine neoplasms: magnetic resonance imaging features according to grade and stage[J]. World J Gastroenterol, 2017, 23(2): 275-285. DOI: 10.3748/wjg.v23.i2.275.
[14]
WANG X W, WU Y B, CAO X F, et al. Duodenal neuroendocrine tumor: A rare case report[J/OL]. Medicine, 2021, 100(6): e24635 [2023-04-07]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886419/. DOI: 10.1097/MD.0000000000024635.
[15]
ITO T, MASUI T, KOMOTO I, et al. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis[J]. J Gastroenterol, 2021, 56(11): 1033-1044. DOI: 10.1007/s00535-021-01827-7.
[16]
AHMED M. Gastrointestinal neuroendocrine tumors in 2020[J]. World J Gastrointest Oncol, 2020, 12(8): 791-807. DOI: 10.4251/wjgo.v12.i8.791.
[17]
DUMLU E G, KARAKOÇ D, ÖZDEMIR A. Nonfunctional pancreatic neuroendocrine tumors: advances in diagnosis, management, and controversies[J]. Int Surg, 2015, 100(6): 1089-1097. DOI: 10.9738/INTSURG-D-14-00204.1.
[18]
NAGTEGAAL I D, ODZE R D, KLIMSTRA D, et al. The 2019 WHO classification of tumours of the digestive system[J]. Histopathology, 2020, 76(2): 182-188. DOI: 10.1111/his.13975.
[19]
INZANI F, RINDI G. Introduction to neuroendocrine neoplasms of the digestive system: definition and classification[J]. Pathologica, 2021, 113(1): 1-4. DOI: 10.32074/1591-951X-227.
[20]
PELLAT A, COTTEREAU A S, TERRIS B, et al. Neuroendocrine carcinomas of the digestive tract: What is new?[J/OL]. Cancers, 2021, 13(15): 3766 [2023-04-02]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345167/. DOI: 10.3390/cancers13153766.
[21]
HOFLAND J, FEELDERS R A, BRABANDER T, et al. Recent developments in the diagnosis and therapy of well-differentiated neuroendocrine tumours[J]. Neth J Med, 2018, 76(3): 100-108.
[22]
KABIR T, ISSA M, STARKEY G. Rare presentation of a symptomatic primary neuroendocrine tumour of small bowel mesentery[J/OL]. ANZ J Surg, 2021, 91(6): E403-E404 [2023-04-10]. https://pubmed.ncbi.nlm.nih.gov/33159428/. DOI: 10.1111/ans.16431.
[23]
ITO T, LEE L, JENSEN R T. Carcinoid-syndrome: recent advances, current status and controversies[J]. Curr Opin Endocrinol Diabetes Obes, 2018, 25(1): 22-35. DOI: 10.1097/MED.0000000000000376.
[24]
DUFAY C, ABDELLI A, LE PENNEC V, et al. Mesenteric tumors: diagnosis and treatment[J/OL]. J Visc Surg, 2012, 149(4): e239-e251 [2023-04-18]. https://pubmed.ncbi.nlm.nih.gov/22796300/. DOI: 10.1016/j.jviscsurg.2012.05.005.
[25]
WEISS S, WEISSE V, KORTHAUS A, et al. Clinical presentation and MRI characteristics of appendicular soft tissue lymphoma: A systematic review[J/OL]. Diagnostics, 2022, 12(7): 1623 [2023-04-03]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320678/. DOI: 10.3390/diagnostics12071623.
[26]
GUO A C, CUMMINGS T J, DASH R C, et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics[J]. Radiology, 2002, 224(1): 177-183. DOI: 10.1148/radiol.2241010637.
[27]
HONG J H, JEE W H, WHANG S, et al. Differentiation of soft-tissue lymphoma from undifferentiated sarcoma: apparent diffusion coefficient histogram analysis[J]. Acta Radiol, 2021, 62(8): 1045-1051. DOI: 10.1177/0284185120951959.
[28]
HU Z W, LIANG P, LI Z L, et al. Diagnostic value and potential clinical significance of duodenal lipoma based on computed tomography imaging data[J/OL]. Medicine, 2021, 100(33): e26944 [2023-04-14]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376382/. DOI: 10.1097/MD.0000000000026944.
[29]
VIJAYAN N, THEKKEVEETTIL M, SUNDARAM S, et al. Giant mesenteric lipoma in an adult[J/OL]. ACG Case Rep J, 2022, 9(1): e00728 [2023-04-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35028324/. DOI: 10.14309/crj.0000000000000728.

PREV A case of MRI manifestation of highly differentiated neuroendocrine tumor in spleen
NEXT The application and progress of dynamic functional connectivity in idiopathic generalized epilepsy
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn